Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Welcome and Introduction to Vi3C

Advertisement

Advertisement




Feb
13
Today In Oncology
ASCO and Conexiant Launch ASCO AI in Oncology
Demographic and Clinicopathologic Factors in Colorectal Adenoma Recurrence Risk
ASH Publishes Clinical Guidelines on AL Amyloidosis Diagnosis
FDA Approves TTFields Device for Pancreatic Cancer
Interval Cancer Rate With AI-Supported Mammography Screening
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo